| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oncolytic Virotherapy | 45 | 2024 | 498 | 6.260 |
Why?
|
| Simplexvirus | 57 | 2022 | 802 | 5.920 |
Why?
|
| Herpesvirus 1, Human | 32 | 2021 | 743 | 3.010 |
Why?
|
| Oncolytic Viruses | 26 | 2023 | 327 | 2.750 |
Why?
|
| Glioblastoma | 44 | 2024 | 3481 | 2.700 |
Why?
|
| Brain Neoplasms | 68 | 2024 | 8863 | 2.110 |
Why?
|
| Meningioma | 33 | 2023 | 1209 | 1.560 |
Why?
|
| Genetic Vectors | 41 | 2018 | 3420 | 1.530 |
Why?
|
| Virus Replication | 35 | 2018 | 2534 | 1.470 |
Why?
|
| Neoplastic Stem Cells | 16 | 2019 | 1376 | 1.440 |
Why?
|
| Interleukin-12 | 9 | 2018 | 579 | 1.420 |
Why?
|
| Antineoplastic Agents, Alkylating | 5 | 2020 | 627 | 1.310 |
Why?
|
| Neuroma, Acoustic | 21 | 2012 | 451 | 1.200 |
Why?
|
| Mice, Nude | 45 | 2014 | 3689 | 1.100 |
Why?
|
| Meningeal Neoplasms | 22 | 2023 | 1241 | 1.070 |
Why?
|
| Glioma | 32 | 2019 | 3401 | 1.020 |
Why?
|
| Neurilemmoma | 13 | 2014 | 547 | 0.920 |
Why?
|
| Angiostatins | 2 | 2013 | 67 | 0.870 |
Why?
|
| Dacarbazine | 4 | 2011 | 566 | 0.820 |
Why?
|
| Neurofibromatosis 1 | 22 | 2004 | 569 | 0.760 |
Why?
|
| Angiogenesis Inhibitors | 7 | 2014 | 2038 | 0.760 |
Why?
|
| Tumor Cells, Cultured | 37 | 2019 | 6314 | 0.740 |
Why?
|
| Herpes Simplex | 9 | 2024 | 470 | 0.690 |
Why?
|
| Neoplasm Transplantation | 29 | 2017 | 2085 | 0.670 |
Why?
|
| Mice | 96 | 2024 | 81183 | 0.590 |
Why?
|
| Vero Cells | 14 | 2018 | 485 | 0.590 |
Why?
|
| Nervous System Neoplasms | 9 | 1992 | 91 | 0.590 |
Why?
|
| Prostatic Neoplasms | 12 | 2012 | 11124 | 0.580 |
Why?
|
| Ganciclovir | 8 | 2001 | 258 | 0.570 |
Why?
|
| Xenograft Model Antitumor Assays | 16 | 2020 | 3557 | 0.560 |
Why?
|
| Neovascularization, Pathologic | 8 | 2018 | 2635 | 0.520 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2018 | 664 | 0.520 |
Why?
|
| Animals | 122 | 2024 | 168757 | 0.490 |
Why?
|
| Combined Modality Therapy | 23 | 2018 | 8642 | 0.490 |
Why?
|
| Cell Line, Tumor | 26 | 2020 | 16689 | 0.470 |
Why?
|
| Neurosurgical Procedures | 6 | 2017 | 2002 | 0.470 |
Why?
|
| Chromosomes, Human, Pair 22 | 13 | 2000 | 351 | 0.460 |
Why?
|
| Neurofibroma | 6 | 2001 | 106 | 0.420 |
Why?
|
| Occipital Lobe | 1 | 2014 | 379 | 0.410 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2012 | 624 | 0.400 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 2011 | 65 | 0.400 |
Why?
|
| Vinblastine | 1 | 2012 | 502 | 0.390 |
Why?
|
| Dilazep | 1 | 2010 | 4 | 0.380 |
Why?
|
| Neuroblastoma | 7 | 2005 | 1226 | 0.380 |
Why?
|
| Neoplasms, Experimental | 9 | 2008 | 1276 | 0.380 |
Why?
|
| Nerve Sheath Neoplasms | 5 | 2014 | 190 | 0.380 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 1 | 2010 | 17 | 0.370 |
Why?
|
| Organ Culture Techniques | 2 | 2010 | 813 | 0.370 |
Why?
|
| Dipyridamole | 1 | 2010 | 145 | 0.360 |
Why?
|
| Etoposide | 1 | 2011 | 641 | 0.360 |
Why?
|
| Mice, Inbred BALB C | 21 | 2012 | 6386 | 0.340 |
Why?
|
| Sesquiterpenes | 3 | 1995 | 177 | 0.330 |
Why?
|
| Retroviridae | 6 | 1997 | 914 | 0.330 |
Why?
|
| Genetic Engineering | 6 | 2009 | 951 | 0.320 |
Why?
|
| Thymidine Kinase | 9 | 2001 | 290 | 0.320 |
Why?
|
| Microsurgery | 1 | 2014 | 796 | 0.320 |
Why?
|
| Immunotherapy | 9 | 2021 | 4445 | 0.310 |
Why?
|
| Psychosurgery | 3 | 2005 | 87 | 0.310 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2010 | 473 | 0.310 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2007 | 122 | 0.280 |
Why?
|
| TCF Transcription Factors | 1 | 2006 | 140 | 0.280 |
Why?
|
| Neurofibromatosis 2 | 6 | 2006 | 380 | 0.280 |
Why?
|
| Ribonucleotide Reductases | 3 | 2010 | 77 | 0.280 |
Why?
|
| Thrombospondins | 1 | 2007 | 197 | 0.280 |
Why?
|
| Disease Models, Animal | 20 | 2020 | 18029 | 0.280 |
Why?
|
| Transfection | 14 | 2006 | 5892 | 0.270 |
Why?
|
| DNA Viruses | 1 | 2005 | 36 | 0.270 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2006 | 85 | 0.270 |
Why?
|
| Viral Vaccines | 3 | 1999 | 636 | 0.270 |
Why?
|
| Brain Diseases | 5 | 2019 | 1563 | 0.260 |
Why?
|
| Taxoids | 1 | 2009 | 666 | 0.260 |
Why?
|
| Cancer Vaccines | 5 | 2001 | 1023 | 0.260 |
Why?
|
| Thrombospondin 1 | 1 | 2007 | 250 | 0.260 |
Why?
|
| Humans | 173 | 2024 | 744343 | 0.260 |
Why?
|
| Hydroxamic Acids | 1 | 2008 | 494 | 0.250 |
Why?
|
| DNA Damage | 3 | 2011 | 2432 | 0.250 |
Why?
|
| Oligodendroglioma | 2 | 2016 | 279 | 0.250 |
Why?
|
| Cytopathogenic Effect, Viral | 8 | 2012 | 156 | 0.250 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2006 | 903 | 0.250 |
Why?
|
| Hematoporphyrins | 4 | 1988 | 23 | 0.250 |
Why?
|
| RNA Viruses | 1 | 2005 | 124 | 0.250 |
Why?
|
| Radiotherapy, Adjuvant | 6 | 2020 | 1770 | 0.250 |
Why?
|
| Chromosome Deletion | 5 | 1997 | 1401 | 0.240 |
Why?
|
| Cytotoxicity, Immunologic | 5 | 2018 | 1369 | 0.240 |
Why?
|
| Antineoplastic Agents | 11 | 2011 | 13695 | 0.240 |
Why?
|
| Facial Paralysis | 2 | 2006 | 338 | 0.230 |
Why?
|
| Virus Shedding | 2 | 2001 | 108 | 0.230 |
Why?
|
| DNA Repair | 4 | 2017 | 2046 | 0.230 |
Why?
|
| Viral Proteins | 6 | 2018 | 1900 | 0.220 |
Why?
|
| Gene Transfer Techniques | 5 | 2010 | 1224 | 0.220 |
Why?
|
| Adenocarcinoma | 5 | 2007 | 6364 | 0.220 |
Why?
|
| Subrenal Capsule Assay | 5 | 1994 | 26 | 0.220 |
Why?
|
| Injections, Intralesional | 5 | 2014 | 276 | 0.220 |
Why?
|
| Tumor Microenvironment | 6 | 2024 | 3586 | 0.210 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2018 | 5535 | 0.210 |
Why?
|
| Cell Division | 9 | 2001 | 4568 | 0.210 |
Why?
|
| Astrocytoma | 6 | 2016 | 790 | 0.210 |
Why?
|
| Gene Deletion | 6 | 2018 | 2751 | 0.210 |
Why?
|
| Biological Therapy | 2 | 2001 | 138 | 0.200 |
Why?
|
| Immunohistochemistry | 11 | 2018 | 11366 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 19 | 2018 | 21827 | 0.200 |
Why?
|
| beta Catenin | 1 | 2006 | 1059 | 0.200 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2020 | 133 | 0.190 |
Why?
|
| Transgenes | 6 | 2021 | 1009 | 0.190 |
Why?
|
| Neurofibromatoses | 2 | 2002 | 299 | 0.180 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2006 | 770 | 0.180 |
Why?
|
| Ethmoid Sinus | 1 | 2000 | 58 | 0.180 |
Why?
|
| Osteomalacia | 1 | 2000 | 53 | 0.180 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 1995 | 692 | 0.180 |
Why?
|
| Hemangiopericytoma | 1 | 2000 | 77 | 0.170 |
Why?
|
| Defective Viruses | 3 | 2000 | 112 | 0.170 |
Why?
|
| Mutation | 19 | 2016 | 29786 | 0.170 |
Why?
|
| Postoperative Complications | 5 | 2012 | 15295 | 0.170 |
Why?
|
| Gyrus Cinguli | 4 | 1995 | 1091 | 0.170 |
Why?
|
| Hypophosphatemia | 1 | 2000 | 85 | 0.170 |
Why?
|
| DNA, Neoplasm | 12 | 1994 | 1758 | 0.170 |
Why?
|
| Cerebellopontine Angle | 4 | 2006 | 55 | 0.170 |
Why?
|
| Cell Survival | 9 | 2017 | 5882 | 0.160 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2023 | 895 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 4751 | 0.160 |
Why?
|
| Stereotaxic Techniques | 4 | 2005 | 536 | 0.160 |
Why?
|
| Female | 84 | 2020 | 380194 | 0.160 |
Why?
|
| Hematoporphyrin Photoradiation | 3 | 1986 | 17 | 0.160 |
Why?
|
| DNA Modification Methylases | 2 | 2011 | 206 | 0.160 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2000 | 151 | 0.160 |
Why?
|
| Pericytes | 1 | 2020 | 292 | 0.160 |
Why?
|
| Fractures, Spontaneous | 1 | 2000 | 230 | 0.160 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2000 | 234 | 0.150 |
Why?
|
| Macrophages | 5 | 2018 | 5655 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 7 | 2022 | 9239 | 0.150 |
Why?
|
| Single-Cell Analysis | 3 | 2016 | 2183 | 0.150 |
Why?
|
| Moloney murine leukemia virus | 3 | 1993 | 139 | 0.150 |
Why?
|
| Transplantation, Heterologous | 9 | 2011 | 2382 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2015 | 3508 | 0.150 |
Why?
|
| DNA Repair Enzymes | 2 | 2011 | 349 | 0.150 |
Why?
|
| Endopeptidases | 1 | 2020 | 772 | 0.150 |
Why?
|
| DNA, Viral | 3 | 2017 | 2225 | 0.140 |
Why?
|
| Rad51 Recombinase | 1 | 2017 | 189 | 0.140 |
Why?
|
| Cell Growth Processes | 2 | 2007 | 399 | 0.140 |
Why?
|
| Obsessive-Compulsive Disorder | 4 | 1995 | 1444 | 0.140 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2006 | 2214 | 0.140 |
Why?
|
| Watchful Waiting | 1 | 2020 | 492 | 0.140 |
Why?
|
| Male | 68 | 2020 | 350118 | 0.140 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2019 | 671 | 0.130 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 1999 | 1821 | 0.130 |
Why?
|
| Cytokines | 4 | 2004 | 7322 | 0.130 |
Why?
|
| Critical Pathways | 1 | 2019 | 476 | 0.130 |
Why?
|
| Phthalazines | 1 | 2017 | 363 | 0.120 |
Why?
|
| Skin Neoplasms | 9 | 2001 | 5686 | 0.120 |
Why?
|
| Sarcoidosis | 1 | 2000 | 506 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 9648 | 0.120 |
Why?
|
| RNA, Messenger | 5 | 2022 | 13033 | 0.120 |
Why?
|
| Rats, Inbred F344 | 6 | 2011 | 862 | 0.120 |
Why?
|
| Peptide Fragments | 1 | 2007 | 5097 | 0.120 |
Why?
|
| Isocitrate Dehydrogenase | 2 | 2016 | 871 | 0.120 |
Why?
|
| Schwann Cells | 6 | 2004 | 195 | 0.120 |
Why?
|
| Lac Operon | 2 | 1992 | 238 | 0.120 |
Why?
|
| Mice, SCID | 5 | 2019 | 2716 | 0.120 |
Why?
|
| Estradiol | 4 | 1986 | 2020 | 0.120 |
Why?
|
| Photochemotherapy | 4 | 1991 | 807 | 0.120 |
Why?
|
| Hearing Disorders | 2 | 1992 | 124 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 987 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2013 | 35421 | 0.110 |
Why?
|
| beta-Galactosidase | 6 | 1995 | 573 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 1992 | 437 | 0.110 |
Why?
|
| Cell Hypoxia | 2 | 2015 | 675 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 5 | 2011 | 6171 | 0.110 |
Why?
|
| Rats | 19 | 2011 | 24260 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2015 | 8428 | 0.110 |
Why?
|
| Biological Products | 2 | 2021 | 860 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 5172 | 0.110 |
Why?
|
| Melanins | 3 | 1999 | 289 | 0.110 |
Why?
|
| Indazoles | 1 | 2014 | 289 | 0.110 |
Why?
|
| Cranial Fossa, Middle | 1 | 2012 | 28 | 0.110 |
Why?
|
| Occipital Bone | 1 | 2012 | 54 | 0.110 |
Why?
|
| Brain | 8 | 2010 | 26385 | 0.110 |
Why?
|
| HeLa Cells | 3 | 2008 | 3128 | 0.110 |
Why?
|
| Radiosurgery | 3 | 2005 | 1329 | 0.110 |
Why?
|
| Ear Neoplasms | 1 | 2013 | 117 | 0.110 |
Why?
|
| Antiviral Agents | 3 | 2001 | 2987 | 0.110 |
Why?
|
| Genes, Neurofibromatosis 1 | 3 | 2004 | 79 | 0.110 |
Why?
|
| Acid Phosphatase | 2 | 2010 | 143 | 0.110 |
Why?
|
| Dexamethasone | 1 | 1999 | 1951 | 0.110 |
Why?
|
| Acyclovir | 1 | 1993 | 272 | 0.110 |
Why?
|
| Tubulin Modulators | 1 | 2012 | 110 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2024 | 4479 | 0.100 |
Why?
|
| Ear, Inner | 2 | 2013 | 420 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 3 | 2018 | 9274 | 0.100 |
Why?
|
| Vaccination | 2 | 2021 | 3278 | 0.100 |
Why?
|
| Transcription, Genetic | 5 | 2006 | 7722 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 627 | 0.100 |
Why?
|
| Mice, Inbred A | 4 | 2011 | 248 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 2 | 2016 | 2012 | 0.100 |
Why?
|
| Onium Compounds | 1 | 1991 | 31 | 0.100 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 1999 | 1524 | 0.100 |
Why?
|
| Immunization | 2 | 2010 | 1256 | 0.100 |
Why?
|
| Tourette Syndrome | 1 | 1994 | 379 | 0.100 |
Why?
|
| Spinal Nerves | 1 | 1991 | 86 | 0.090 |
Why?
|
| Cell Cycle Proteins | 3 | 2019 | 3462 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2006 | 4253 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 1114 | 0.090 |
Why?
|
| Apoptosis | 8 | 2017 | 9727 | 0.090 |
Why?
|
| Signal Transduction | 7 | 2018 | 23403 | 0.090 |
Why?
|
| Sciatic Nerve | 2 | 2001 | 607 | 0.090 |
Why?
|
| Clinical Trials as Topic | 2 | 2005 | 7913 | 0.090 |
Why?
|
| Vestibule, Labyrinth | 1 | 2012 | 235 | 0.090 |
Why?
|
| Cobalt Radioisotopes | 2 | 1988 | 76 | 0.090 |
Why?
|
| Injections | 2 | 2011 | 840 | 0.090 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2010 | 129 | 0.090 |
Why?
|
| Organophosphorus Compounds | 1 | 1991 | 215 | 0.090 |
Why?
|
| Neuroma | 1 | 1991 | 103 | 0.090 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1992 | 689 | 0.090 |
Why?
|
| Recombinases | 2 | 2006 | 67 | 0.090 |
Why?
|
| Ki-67 Antigen | 3 | 2017 | 644 | 0.090 |
Why?
|
| Cyclohexanes | 3 | 1995 | 152 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 5 | 2017 | 3616 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 2007 | 0.090 |
Why?
|
| Encephalitis | 1 | 1993 | 423 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2018 | 4386 | 0.090 |
Why?
|
| Treatment Outcome | 13 | 2020 | 63114 | 0.090 |
Why?
|
| Blotting, Western | 3 | 2017 | 5179 | 0.090 |
Why?
|
| Immediate-Early Proteins | 2 | 2001 | 453 | 0.090 |
Why?
|
| Flow Cytometry | 3 | 2013 | 5974 | 0.080 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 1989 | 44 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2013 | 721 | 0.080 |
Why?
|
| Y Chromosome | 1 | 1990 | 206 | 0.080 |
Why?
|
| Methylation | 1 | 2011 | 1106 | 0.080 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2012 | 491 | 0.080 |
Why?
|
| Base Sequence | 6 | 2006 | 12797 | 0.080 |
Why?
|
| Neural Stem Cells | 2 | 2016 | 851 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2011 | 2849 | 0.080 |
Why?
|
| Aotidae | 2 | 2000 | 59 | 0.080 |
Why?
|
| Neural Cell Adhesion Molecules | 2 | 2000 | 126 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2011 | 1682 | 0.080 |
Why?
|
| Mammary Glands, Human | 1 | 2009 | 199 | 0.080 |
Why?
|
| Neoplasms, Nerve Tissue | 1 | 1988 | 23 | 0.080 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2001 | 282 | 0.080 |
Why?
|
| Melanoma | 2 | 2024 | 5510 | 0.080 |
Why?
|
| Camptothecin | 1 | 2011 | 576 | 0.080 |
Why?
|
| Cytotoxicity Tests, Immunologic | 4 | 2001 | 329 | 0.080 |
Why?
|
| Cell Line | 13 | 2012 | 15997 | 0.080 |
Why?
|
| Tumor Stem Cell Assay | 3 | 2017 | 118 | 0.080 |
Why?
|
| Imidazoles | 1 | 2014 | 1206 | 0.080 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2008 | 192 | 0.080 |
Why?
|
| Bone Marrow | 1 | 2018 | 2948 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 3870 | 0.080 |
Why?
|
| Peroxidase | 1 | 2011 | 611 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2001 | 3772 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 2 | 1992 | 1097 | 0.080 |
Why?
|
| Lasers | 1 | 1992 | 952 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2000 | 10943 | 0.080 |
Why?
|
| Cell Cycle | 2 | 2017 | 2967 | 0.080 |
Why?
|
| Random Allocation | 3 | 2014 | 2429 | 0.080 |
Why?
|
| Membrane Proteins | 3 | 2020 | 7880 | 0.080 |
Why?
|
| Genes, Neoplasm | 1 | 2009 | 376 | 0.080 |
Why?
|
| Cell Proliferation | 8 | 2019 | 10481 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2727 | 0.070 |
Why?
|
| Edema | 1 | 2011 | 789 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 1655 | 0.070 |
Why?
|
| Brain Chemistry | 1 | 1990 | 981 | 0.070 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1991 | 604 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2006 | 6773 | 0.070 |
Why?
|
| Tumor Burden | 1 | 2012 | 1915 | 0.070 |
Why?
|
| Safety | 2 | 2005 | 1186 | 0.070 |
Why?
|
| Platelet Factor 4 | 1 | 2006 | 129 | 0.070 |
Why?
|
| Piperazines | 1 | 2017 | 2488 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 4 | 2014 | 4462 | 0.070 |
Why?
|
| Comet Assay | 1 | 2006 | 71 | 0.070 |
Why?
|
| Cyclin D1 | 1 | 2008 | 463 | 0.070 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2006 | 185 | 0.070 |
Why?
|
| Cerebellar Neoplasms | 3 | 1987 | 587 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2011 | 2503 | 0.070 |
Why?
|
| Hearing Loss | 2 | 2009 | 765 | 0.070 |
Why?
|
| Caco-2 Cells | 1 | 2006 | 387 | 0.070 |
Why?
|
| Antibodies, Viral | 4 | 2000 | 3176 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2007 | 9734 | 0.070 |
Why?
|
| Tandem Repeat Sequences | 1 | 2006 | 185 | 0.070 |
Why?
|
| Chromosome Disorders | 2 | 1988 | 514 | 0.070 |
Why?
|
| Arachnoid | 2 | 1985 | 48 | 0.070 |
Why?
|
| Mental Disorders | 2 | 2005 | 6600 | 0.070 |
Why?
|
| HCT116 Cells | 1 | 2006 | 408 | 0.070 |
Why?
|
| Protein Phosphatase 1 | 1 | 2006 | 137 | 0.070 |
Why?
|
| Ethics Committees, Clinical | 1 | 2005 | 56 | 0.060 |
Why?
|
| Genes, MHC Class I | 1 | 2006 | 258 | 0.060 |
Why?
|
| Neurosurgery | 1 | 1992 | 643 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 5 | 2006 | 5867 | 0.060 |
Why?
|
| Blood Proteins | 1 | 2010 | 1124 | 0.060 |
Why?
|
| Postoperative Period | 3 | 2020 | 1842 | 0.060 |
Why?
|
| Middle Aged | 33 | 2020 | 213383 | 0.060 |
Why?
|
| Antigens, Differentiation | 2 | 2006 | 927 | 0.060 |
Why?
|
| RNA, Small Interfering | 3 | 2013 | 3505 | 0.060 |
Why?
|
| Cell Culture Techniques | 2 | 2018 | 1678 | 0.060 |
Why?
|
| Cranial Nerve Neoplasms | 2 | 1985 | 129 | 0.060 |
Why?
|
| Melanosis | 1 | 1985 | 78 | 0.060 |
Why?
|
| Mice, Inbred Strains | 3 | 2007 | 1827 | 0.060 |
Why?
|
| Aotus trivirgatus | 2 | 2001 | 37 | 0.060 |
Why?
|
| Injections, Subcutaneous | 3 | 2001 | 666 | 0.060 |
Why?
|
| Guanine | 1 | 2006 | 274 | 0.060 |
Why?
|
| Chromosomes, Artificial, Bacterial | 3 | 2012 | 126 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 2 | 2000 | 425 | 0.060 |
Why?
|
| Adenoviridae | 2 | 2020 | 1099 | 0.060 |
Why?
|
| Gene Expression | 8 | 2009 | 7799 | 0.060 |
Why?
|
| Carrier Proteins | 4 | 2002 | 5021 | 0.060 |
Why?
|
| Interleukin-18 | 1 | 2005 | 249 | 0.060 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 3798 | 0.060 |
Why?
|
| Tamoxifen | 2 | 1986 | 981 | 0.060 |
Why?
|
| Growth Substances | 1 | 1986 | 784 | 0.060 |
Why?
|
| Stem Cell Factor | 1 | 2004 | 219 | 0.060 |
Why?
|
| Neurofibromin 1 | 2 | 2002 | 196 | 0.060 |
Why?
|
| Progesterone | 2 | 1985 | 776 | 0.060 |
Why?
|
| Endothelium, Vascular | 4 | 2008 | 4456 | 0.060 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2009 | 496 | 0.060 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2005 | 227 | 0.060 |
Why?
|
| Hematoporphyrin Derivative | 3 | 1988 | 10 | 0.060 |
Why?
|
| Mitogens | 2 | 2001 | 232 | 0.060 |
Why?
|
| Laser Therapy | 1 | 1990 | 1072 | 0.060 |
Why?
|
| Adult | 35 | 2019 | 214055 | 0.060 |
Why?
|
| Neoplasms | 6 | 2021 | 21683 | 0.060 |
Why?
|
| Genes, p53 | 1 | 2006 | 755 | 0.060 |
Why?
|
| Prognosis | 8 | 2019 | 29063 | 0.060 |
Why?
|
| ras Proteins | 1 | 2008 | 1060 | 0.060 |
Why?
|
| Heparin | 1 | 1990 | 1637 | 0.060 |
Why?
|
| Progestins | 1 | 1985 | 306 | 0.060 |
Why?
|
| Cranial Nerves | 1 | 2003 | 101 | 0.060 |
Why?
|
| Polymorphism, Restriction Fragment Length | 4 | 1991 | 768 | 0.060 |
Why?
|
| Audiometry, Evoked Response | 4 | 1992 | 44 | 0.050 |
Why?
|
| Herpesvirus 2, Human | 1 | 2024 | 189 | 0.050 |
Why?
|
| History, 19th Century | 1 | 2005 | 720 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 1990 | 1826 | 0.050 |
Why?
|
| Disease Progression | 5 | 2019 | 13284 | 0.050 |
Why?
|
| Sarcoma, Myeloid | 1 | 2003 | 59 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2019 | 2618 | 0.050 |
Why?
|
| Karyotyping | 3 | 1991 | 1243 | 0.050 |
Why?
|
| Plasmids | 2 | 2006 | 2307 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2004 | 2942 | 0.050 |
Why?
|
| Temperature | 3 | 2000 | 2206 | 0.050 |
Why?
|
| Pituitary Neoplasms | 1 | 1990 | 1345 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 1988 | 1813 | 0.050 |
Why?
|
| Blotting, Southern | 3 | 1991 | 803 | 0.050 |
Why?
|
| Cytosol | 1 | 1985 | 901 | 0.050 |
Why?
|
| Facial Neuralgia | 1 | 1981 | 10 | 0.050 |
Why?
|
| T-Lymphocytes | 2 | 2018 | 10180 | 0.050 |
Why?
|
| Blood-Brain Barrier | 2 | 2005 | 1017 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2016 | 9438 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 13102 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 708 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2006 | 1792 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 1294 | 0.050 |
Why?
|
| Primates | 2 | 2001 | 545 | 0.050 |
Why?
|
| Bone Marrow Purging | 1 | 2001 | 109 | 0.050 |
Why?
|
| Survival Analysis | 4 | 2014 | 10252 | 0.050 |
Why?
|
| Aged | 23 | 2020 | 163280 | 0.050 |
Why?
|
| Alleles | 5 | 2002 | 6933 | 0.050 |
Why?
|
| Retrospective Studies | 11 | 2020 | 77449 | 0.050 |
Why?
|
| Nervous System Diseases | 1 | 1992 | 1622 | 0.050 |
Why?
|
| Interferon-gamma | 2 | 2008 | 3206 | 0.050 |
Why?
|
| Organ Size | 1 | 2006 | 2252 | 0.050 |
Why?
|
| Melanocytes | 1 | 1984 | 515 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 1213 | 0.050 |
Why?
|
| Neuroendocrine Tumors | 1 | 2007 | 594 | 0.050 |
Why?
|
| Protein Kinase C | 2 | 1996 | 1227 | 0.050 |
Why?
|
| Radiation, Ionizing | 1 | 2001 | 258 | 0.050 |
Why?
|
| Haplorhini | 1 | 2001 | 552 | 0.050 |
Why?
|
| Skin | 4 | 2004 | 4364 | 0.050 |
Why?
|
| DNA Primers | 2 | 2005 | 2892 | 0.050 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 1999 | 62 | 0.050 |
Why?
|
| Genetic Markers | 8 | 1997 | 2634 | 0.050 |
Why?
|
| Fibroblasts | 1 | 1990 | 4161 | 0.040 |
Why?
|
| Cells, Cultured | 10 | 2014 | 19229 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2020 | 188 | 0.040 |
Why?
|
| Astrocytes | 3 | 2013 | 1270 | 0.040 |
Why?
|
| Cysts | 2 | 1985 | 678 | 0.040 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 2 | 2012 | 197 | 0.040 |
Why?
|
| Adenoma | 1 | 1990 | 2174 | 0.040 |
Why?
|
| World Health Organization | 2 | 2015 | 1318 | 0.040 |
Why?
|
| Tears | 1 | 2000 | 256 | 0.040 |
Why?
|
| Microscopy, Electron | 3 | 1990 | 2645 | 0.040 |
Why?
|
| Electric Stimulation Therapy | 1 | 2005 | 605 | 0.040 |
Why?
|
| Follow-Up Studies | 9 | 2015 | 39050 | 0.040 |
Why?
|
| Drug Resistance | 3 | 1994 | 1609 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2004 | 817 | 0.040 |
Why?
|
| Time Factors | 10 | 2006 | 40075 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2006 | 18111 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2014 | 6544 | 0.040 |
Why?
|
| Neurites | 2 | 2000 | 388 | 0.040 |
Why?
|
| Breast Neoplasms | 3 | 2005 | 20822 | 0.040 |
Why?
|
| Brain Injuries | 1 | 1990 | 2025 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11524 | 0.040 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2009 | 1632 | 0.040 |
Why?
|
| Sarcoma | 1 | 1990 | 1897 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2001 | 4560 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 6622 | 0.040 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1999 | 191 | 0.040 |
Why?
|
| Androgens | 1 | 2005 | 1281 | 0.040 |
Why?
|
| Estrogens | 1 | 1985 | 1566 | 0.040 |
Why?
|
| Somatostatin | 1 | 2000 | 459 | 0.040 |
Why?
|
| Glutamate Decarboxylase | 1 | 1998 | 245 | 0.040 |
Why?
|
| Genes, Neurofibromatosis 2 | 2 | 2000 | 124 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 2938 | 0.040 |
Why?
|
| Receptors, Estrogen | 2 | 1986 | 2187 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2008 | 2725 | 0.040 |
Why?
|
| Viruses | 1 | 2001 | 374 | 0.040 |
Why?
|
| Mitotic Index | 1 | 2017 | 172 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2022 | 789 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2020 | 491 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2005 | 2740 | 0.040 |
Why?
|
| Quinazolinones | 1 | 2019 | 221 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2000 | 561 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2024 | 1904 | 0.040 |
Why?
|
| Diphtheria Toxin | 1 | 1997 | 255 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 4851 | 0.040 |
Why?
|
| Lymphoid Tissue | 1 | 2018 | 455 | 0.040 |
Why?
|
| Antibodies, Neoplasm | 2 | 1976 | 286 | 0.040 |
Why?
|
| Thionucleotides | 1 | 1996 | 107 | 0.040 |
Why?
|
| Transferrin | 1 | 1997 | 295 | 0.040 |
Why?
|
| Saliva | 1 | 2000 | 809 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 1997 | 299 | 0.030 |
Why?
|
| Chromosome Mapping | 7 | 1997 | 4740 | 0.030 |
Why?
|
| Sphingosine | 1 | 2018 | 307 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2019 | 20129 | 0.030 |
Why?
|
| Lymphopenia | 1 | 2018 | 285 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 1985 | 2969 | 0.030 |
Why?
|
| Lysophospholipids | 1 | 2018 | 331 | 0.030 |
Why?
|
| Survival Rate | 4 | 2010 | 12788 | 0.030 |
Why?
|
| Cell Differentiation | 4 | 2016 | 11483 | 0.030 |
Why?
|
| Herpesviridae | 1 | 1996 | 109 | 0.030 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2005 | 1344 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2000 | 2031 | 0.030 |
Why?
|
| Receptors, Progesterone | 3 | 1986 | 1097 | 0.030 |
Why?
|
| Vagina | 1 | 2000 | 825 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2001 | 1284 | 0.030 |
Why?
|
| Leukocytes | 5 | 1990 | 2043 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2020 | 1355 | 0.030 |
Why?
|
| DNA, Antisense | 1 | 1994 | 46 | 0.030 |
Why?
|
| Radiotherapy Dosage | 3 | 2005 | 2879 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 440 | 0.030 |
Why?
|
| Biopsy | 3 | 2019 | 6756 | 0.030 |
Why?
|
| Cerebellum | 2 | 2000 | 1488 | 0.030 |
Why?
|
| DNA Probes | 3 | 1991 | 560 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2019 | 1663 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2001 | 1366 | 0.030 |
Why?
|
| Hearing | 2 | 2009 | 482 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 1999 | 1537 | 0.030 |
Why?
|
| Escherichia coli | 3 | 1992 | 4217 | 0.030 |
Why?
|
| Vaccines, Attenuated | 1 | 1995 | 342 | 0.030 |
Why?
|
| Digoxin | 1 | 2015 | 250 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2017 | 558 | 0.030 |
Why?
|
| Cerebral Angiography | 1 | 2000 | 1285 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2005 | 2972 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1996 | 433 | 0.030 |
Why?
|
| Restriction Mapping | 2 | 1991 | 878 | 0.030 |
Why?
|
| Endocytosis | 1 | 2018 | 985 | 0.030 |
Why?
|
| DNA | 5 | 2009 | 7301 | 0.030 |
Why?
|
| Recombination, Genetic | 2 | 1997 | 1586 | 0.030 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2015 | 284 | 0.030 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2013 | 64 | 0.030 |
Why?
|
| Skull Base Neoplasms | 1 | 2017 | 284 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2014 | 194 | 0.030 |
Why?
|
| Isoenzymes | 2 | 1996 | 1726 | 0.030 |
Why?
|
| Optic Nerve | 1 | 1977 | 554 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 2219 | 0.030 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1973 | 45 | 0.030 |
Why?
|
| Facial Nerve | 3 | 1987 | 271 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2001 | 2513 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2000 | 1406 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2003 | 2925 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 386 | 0.030 |
Why?
|
| Cisplatin | 1 | 1999 | 1662 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 2018 | 1903 | 0.030 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2014 | 186 | 0.030 |
Why?
|
| Body Weight | 2 | 1995 | 4669 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 2006 | 4320 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2001 | 1928 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 1741 | 0.030 |
Why?
|
| Virus Latency | 1 | 1995 | 358 | 0.030 |
Why?
|
| Prostate | 1 | 2001 | 1774 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 1995 | 477 | 0.030 |
Why?
|
| Mutagenesis | 2 | 2000 | 1266 | 0.030 |
Why?
|
| Plasmacytoma | 1 | 1993 | 183 | 0.030 |
Why?
|
| Transplantation, Isogeneic | 1 | 2012 | 257 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1998 | 1121 | 0.030 |
Why?
|
| Radiation Tolerance | 1 | 1994 | 486 | 0.030 |
Why?
|
| Spleen | 1 | 2018 | 2362 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 1607 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2008 | 3701 | 0.030 |
Why?
|
| Gene Order | 1 | 2012 | 176 | 0.030 |
Why?
|
| Phosphonoacetic Acid | 1 | 1991 | 55 | 0.030 |
Why?
|
| Heterozygote | 3 | 1999 | 2804 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 1992 | 287 | 0.030 |
Why?
|
| Foscarnet | 1 | 1991 | 38 | 0.030 |
Why?
|
| Virulence | 1 | 1995 | 1333 | 0.020 |
Why?
|
| Dequalinium | 1 | 1991 | 8 | 0.020 |
Why?
|
| Temporal Bone | 3 | 1991 | 661 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 1995 | 1547 | 0.020 |
Why?
|
| Interferon-beta | 1 | 2013 | 323 | 0.020 |
Why?
|
| Inflammation | 1 | 2011 | 10638 | 0.020 |
Why?
|
| Neurons | 3 | 2000 | 9338 | 0.020 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 1992 | 250 | 0.020 |
Why?
|
| Genome, Viral | 1 | 1995 | 667 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 1995 | 1525 | 0.020 |
Why?
|
| Point Mutation | 1 | 2016 | 1623 | 0.020 |
Why?
|
| Neuroglia | 1 | 2016 | 927 | 0.020 |
Why?
|
| Pedigree | 4 | 1992 | 4644 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2012 | 190 | 0.020 |
Why?
|
| Recurrence | 2 | 2017 | 8340 | 0.020 |
Why?
|
| Autophagy | 2 | 2012 | 1300 | 0.020 |
Why?
|
| Speech Discrimination Tests | 2 | 1992 | 35 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2013 | 6538 | 0.020 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 1990 | 159 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 1994 | 669 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1991 | 708 | 0.020 |
Why?
|
| Risk Factors | 3 | 2019 | 72290 | 0.020 |
Why?
|
| DNA Replication | 1 | 2017 | 1399 | 0.020 |
Why?
|
| Adolescent | 11 | 2015 | 85781 | 0.020 |
Why?
|
| Vidarabine | 1 | 1991 | 345 | 0.020 |
Why?
|
| Consumer Product Safety | 2 | 2001 | 122 | 0.020 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 57776 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 1993 | 1147 | 0.020 |
Why?
|
| Hybridomas | 1 | 1990 | 452 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2000 | 3768 | 0.020 |
Why?
|
| Oncogenes | 2 | 1987 | 1265 | 0.020 |
Why?
|
| Phylogeny | 1 | 2016 | 2803 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1992 | 2186 | 0.020 |
Why?
|
| Child | 8 | 2004 | 77709 | 0.020 |
Why?
|
| Lymphocytes | 2 | 1990 | 2617 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 1995 | 6038 | 0.020 |
Why?
|
| Bystander Effect | 1 | 2009 | 81 | 0.020 |
Why?
|
| Introns | 1 | 1991 | 991 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 1973 | 1035 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2009 | 323 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 1999 | 12072 | 0.020 |
Why?
|
| Young Adult | 4 | 2019 | 56430 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 1990 | 635 | 0.020 |
Why?
|
| Spinal Cord Neoplasms | 1 | 1991 | 281 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 1992 | 665 | 0.020 |
Why?
|
| Antineoplastic Protocols | 1 | 2008 | 50 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 1941 | 0.020 |
Why?
|
| Disease Management | 1 | 2019 | 2459 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1999 | 4034 | 0.020 |
Why?
|
| Gene Amplification | 1 | 1992 | 1063 | 0.020 |
Why?
|
| Epigenomics | 1 | 2013 | 903 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2012 | 8436 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1987 | 570 | 0.020 |
Why?
|
| Indoles | 2 | 1994 | 1839 | 0.020 |
Why?
|
| Medulloblastoma | 1 | 1992 | 683 | 0.020 |
Why?
|
| X Chromosome | 1 | 1990 | 814 | 0.020 |
Why?
|
| Glia Maturation Factor | 1 | 1986 | 15 | 0.020 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 1 | 1986 | 46 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 1799 | 0.020 |
Why?
|
| Capgras Syndrome | 1 | 1986 | 9 | 0.020 |
Why?
|
| Protein Binding | 1 | 2019 | 9386 | 0.020 |
Why?
|
| Bone Density | 1 | 2000 | 3468 | 0.020 |
Why?
|
| Genome, Human | 2 | 2009 | 4420 | 0.020 |
Why?
|
| Adenine | 1 | 2012 | 936 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 1157 | 0.020 |
Why?
|
| Methylnitrosourea | 1 | 1986 | 29 | 0.020 |
Why?
|
| Central Nervous System | 1 | 1994 | 1357 | 0.020 |
Why?
|
| Craniotomy | 1 | 1990 | 729 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 625 | 0.020 |
Why?
|
| Selection Bias | 1 | 2008 | 371 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 1 | 1992 | 957 | 0.020 |
Why?
|
| Culture Techniques | 2 | 1977 | 554 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2009 | 913 | 0.020 |
Why?
|
| Tritium | 1 | 1986 | 745 | 0.020 |
Why?
|
| Receptors, Estradiol | 1 | 1985 | 19 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2000 | 12959 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1676 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1987 | 1375 | 0.020 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1990 | 547 | 0.020 |
Why?
|
| Corpus Striatum | 1 | 1992 | 1221 | 0.020 |
Why?
|
| Cell Movement | 2 | 2009 | 5217 | 0.020 |
Why?
|
| Caloric Tests | 1 | 1985 | 10 | 0.020 |
Why?
|
| Myelography | 2 | 1982 | 69 | 0.020 |
Why?
|
| Albumins | 2 | 1999 | 569 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 2006 | 476 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 1986 | 295 | 0.020 |
Why?
|
| Osmosis | 1 | 2005 | 113 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 1538 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1991 | 685 | 0.020 |
Why?
|
| Injections, Intra-Arterial | 1 | 2005 | 193 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2007 | 758 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 1526 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 1999 | 2734 | 0.020 |
Why?
|
| Glomus Jugulare Tumor | 1 | 1985 | 37 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 6895 | 0.020 |
Why?
|
| Hospitals | 1 | 2019 | 3952 | 0.020 |
Why?
|
| Albinism | 1 | 1984 | 25 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2017 | 23338 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2006 | 982 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2015 | 4026 | 0.020 |
Why?
|
| Cell Line, Transformed | 2 | 1997 | 898 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 1985 | 155 | 0.020 |
Why?
|
| Monophenol Monooxygenase | 1 | 1984 | 69 | 0.020 |
Why?
|
| Kinetics | 2 | 2011 | 6473 | 0.020 |
Why?
|
| RNA Interference | 1 | 2013 | 2889 | 0.020 |
Why?
|
| Drug Implants | 1 | 2005 | 244 | 0.010 |
Why?
|
| Audiometry | 1 | 1985 | 241 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1992 | 1917 | 0.010 |
Why?
|
| Reoperation | 1 | 1994 | 4201 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2006 | 880 | 0.010 |
Why?
|
| DNA Mutational Analysis | 2 | 2004 | 4186 | 0.010 |
Why?
|
| Genes | 1 | 1987 | 1893 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1984 | 719 | 0.010 |
Why?
|
| Phenotype | 3 | 2011 | 16365 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2007 | 2327 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2001 | 5442 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 1983 | 278 | 0.010 |
Why?
|
| Cohort Studies | 3 | 2015 | 40561 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1986 | 1572 | 0.010 |
Why?
|
| Metrizamide | 1 | 1982 | 17 | 0.010 |
Why?
|
| Promegestone | 1 | 1981 | 9 | 0.010 |
Why?
|
| Lipoma | 1 | 1985 | 334 | 0.010 |
Why?
|
| Genotype | 2 | 2011 | 12951 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1984 | 964 | 0.010 |
Why?
|
| Nevus, Pigmented | 1 | 1984 | 219 | 0.010 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 1982 | 49 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2019 | 4468 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2007 | 1539 | 0.010 |
Why?
|
| Arteriovenous Malformations | 1 | 1985 | 396 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 2 | 1999 | 1341 | 0.010 |
Why?
|
| Brain Edema | 1 | 1986 | 617 | 0.010 |
Why?
|
| Aneurysm | 1 | 1985 | 339 | 0.010 |
Why?
|
| Dogs | 1 | 1986 | 3912 | 0.010 |
Why?
|
| Chromatin | 1 | 2013 | 2934 | 0.010 |
Why?
|
| Age of Onset | 2 | 2000 | 3271 | 0.010 |
Why?
|
| Immunotherapy, Active | 1 | 2001 | 60 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1991 | 2948 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1990 | 1861 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 3647 | 0.010 |
Why?
|
| Eye Neoplasms | 1 | 1983 | 313 | 0.010 |
Why?
|
| Lod Score | 2 | 1992 | 614 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3920 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 2005 | 952 | 0.010 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2000 | 88 | 0.010 |
Why?
|
| Lipomatosis | 1 | 1981 | 112 | 0.010 |
Why?
|
| Biological Transport | 1 | 2005 | 2118 | 0.010 |
Why?
|
| Retinoblastoma | 1 | 1983 | 318 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1990 | 6489 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1983 | 641 | 0.010 |
Why?
|
| Cochlear Nerve | 1 | 1982 | 197 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2005 | 1285 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2010 | 21746 | 0.010 |
Why?
|
| Hemangioma | 1 | 1985 | 738 | 0.010 |
Why?
|
| Cushing Syndrome | 1 | 1981 | 249 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 7659 | 0.010 |
Why?
|
| Genes, Insect | 1 | 2000 | 268 | 0.010 |
Why?
|
| K562 Cells | 1 | 2001 | 634 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2008 | 3479 | 0.010 |
Why?
|
| Microglia | 1 | 2007 | 1266 | 0.010 |
Why?
|
| RNA | 1 | 2009 | 2749 | 0.010 |
Why?
|
| Spinal Cord Compression | 1 | 1981 | 235 | 0.010 |
Why?
|
| Neurofibromin 2 | 1 | 2000 | 267 | 0.010 |
Why?
|
| Solubility | 1 | 2001 | 1085 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1991 | 3703 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2001 | 279 | 0.010 |
Why?
|
| Insect Proteins | 1 | 2000 | 258 | 0.010 |
Why?
|
| Eye Diseases | 1 | 1984 | 669 | 0.010 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 1986 | 1018 | 0.010 |
Why?
|
| Kainic Acid | 1 | 1998 | 199 | 0.010 |
Why?
|
| Genetic Linkage | 3 | 1990 | 2421 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 3079 | 0.010 |
Why?
|
| Hamartoma | 1 | 2000 | 238 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 2699 | 0.010 |
Why?
|
| Protons | 1 | 2003 | 1127 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2000 | 1454 | 0.010 |
Why?
|
| Risk Management | 1 | 2001 | 571 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1990 | 4397 | 0.010 |
Why?
|
| Parents | 1 | 1991 | 3407 | 0.010 |
Why?
|
| Mosaicism | 1 | 2000 | 441 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1999 | 599 | 0.010 |
Why?
|
| Glycosylation | 1 | 2000 | 1126 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 1990 | 3848 | 0.010 |
Why?
|
| Proteomics | 1 | 2010 | 3638 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1984 | 1547 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1999 | 1681 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2000 | 1866 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2000 | 880 | 0.010 |
Why?
|
| Neurology | 1 | 2005 | 763 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2004 | 1788 | 0.010 |
Why?
|
| Models, Genetic | 1 | 1987 | 3494 | 0.010 |
Why?
|
| United States | 1 | 2024 | 69872 | 0.010 |
Why?
|
| Glutamates | 1 | 1976 | 398 | 0.010 |
Why?
|
| Cervical Vertebrae | 1 | 1982 | 975 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2000 | 1730 | 0.010 |
Why?
|
| Goals | 1 | 2000 | 706 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2000 | 1152 | 0.010 |
Why?
|
| Protein Kinase C-alpha | 1 | 1994 | 112 | 0.010 |
Why?
|
| G2 Phase | 1 | 1994 | 139 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1985 | 3760 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2005 | 15076 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2014 | 12208 | 0.010 |
Why?
|
| Polymorphism, Genetic | 2 | 1997 | 4328 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12245 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 2000 | 683 | 0.010 |
Why?
|
| Cataract | 1 | 2000 | 834 | 0.010 |
Why?
|
| Sickness Impact Profile | 1 | 1995 | 302 | 0.010 |
Why?
|
| Models, Animal | 1 | 2000 | 2171 | 0.010 |
Why?
|
| Immunoconjugates | 1 | 2001 | 901 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 1993 | 230 | 0.010 |
Why?
|
| Speech Reception Threshold Test | 1 | 1992 | 17 | 0.010 |
Why?
|
| Spinal Neoplasms | 1 | 2000 | 760 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 3846 | 0.010 |
Why?
|
| Ependyma | 1 | 1973 | 54 | 0.010 |
Why?
|
| Cerebral Aqueduct | 1 | 1973 | 39 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 3617 | 0.010 |
Why?
|
| Medical Oncology | 1 | 2005 | 2265 | 0.010 |
Why?
|
| Age Factors | 1 | 2009 | 18370 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2004 | 3479 | 0.010 |
Why?
|
| Lung | 2 | 2005 | 9856 | 0.010 |
Why?
|
| Psychotic Disorders | 1 | 1986 | 3046 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 2050 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2000 | 1708 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 3396 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1992 | 798 | 0.010 |
Why?
|
| Probability | 1 | 1995 | 2505 | 0.010 |
Why?
|
| Liver | 1 | 2005 | 7474 | 0.010 |
Why?
|
| Behavior Therapy | 1 | 1995 | 865 | 0.010 |
Why?
|
| Cricetinae | 1 | 1973 | 2472 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2001 | 2541 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2004 | 41006 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2001 | 3386 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 1993 | 1000 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1998 | 8301 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2003 | 3523 | 0.000 |
Why?
|
| Intraoperative Period | 1 | 1987 | 520 | 0.000 |
Why?
|
| Hydrocephalus | 1 | 1973 | 748 | 0.000 |
Why?
|
| Cerebral Arterial Diseases | 1 | 1986 | 82 | 0.000 |
Why?
|
| Pain | 1 | 1981 | 4986 | 0.000 |
Why?
|
| Psychotropic Drugs | 1 | 1991 | 894 | 0.000 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1987 | 525 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1992 | 6459 | 0.000 |
Why?
|
| Psychotherapy | 1 | 1991 | 1643 | 0.000 |
Why?
|
| Cauda Equina | 1 | 1981 | 42 | 0.000 |
Why?
|
| Comorbidity | 1 | 1995 | 10388 | 0.000 |
Why?
|
| Epidural Space | 1 | 1981 | 124 | 0.000 |
Why?
|
| Monitoring, Physiologic | 1 | 1987 | 1738 | 0.000 |
Why?
|
| Nerve Compression Syndromes | 1 | 1981 | 160 | 0.000 |
Why?
|
| Disease Susceptibility | 1 | 1987 | 1782 | 0.000 |
Why?
|
| Angiography | 1 | 1985 | 1639 | 0.000 |
Why?
|
| Forecasting | 1 | 1987 | 2951 | 0.000 |
Why?
|
| Intracranial Aneurysm | 1 | 1986 | 1197 | 0.000 |
Why?
|
| Radiography | 1 | 1986 | 7023 | 0.000 |
Why?
|
| Infant | 1 | 1977 | 35136 | 0.000 |
Why?
|
| Quality of Life | 1 | 1995 | 12804 | 0.000 |
Why?
|
| Sodium | 1 | 1976 | 1623 | 0.000 |
Why?
|
| Acute Disease | 1 | 1982 | 7149 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1995 | 53288 | 0.000 |
Why?
|